Evaluation of oral Lanzhou lamb rotavirus vaccine via passive transfusion with CD4+/CD8+ T lymphocytes  by Du, Jialiang et al.
E
t
J
T
a
b
c
a
A
R
R
A
A
K
T
C
R
N
L
1
w
d
o
r
H
S
t
h
d
a
h
0
0Virus Research 217 (2016) 101–106
Contents lists available at ScienceDirect
Virus  Research
j ourna l h o mepa ge: www.elsev ier .com/ locate /v i rusres
valuation  of  oral  Lanzhou  lamb  rotavirus  vaccine  via  passive
ransfusion  with  CD4+/CD8+ T  lymphocytes
ialiang  Dua,1,  Zhiling  Lana,b,1, Yueyue  Liua, Yan  Liua, Qingchuan  Yua,  Yanchao  Lia,c,
ai Guoa,∗
Division of Enteric Viral Vaccines, National Institutes for Food and Drug Control, Beijing, 100050, China
National Vaccine & Serum Institute, Beijing, China
University of Pennsylvania, USA
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 4 August 2015
eceived in revised form 29 January 2016
ccepted 10 March 2016
vailable online 26 March 2016
eywords:
ransfusion
D4+/CD8+ T lymphocytes
otavirus vaccine
ude mouse
LR
a  b  s  t  r  a  c  t
Lanzhou  Lamb  derived  Rotavirus  (RV)  Vaccine  (namely  LLR)  for children  is  only used in  China.  Since  there
were  no  reports  on  evaluation  of LLR, even  the  data  of phase  IV  clinical  trial,  we  proceed  the  evaluation  of
LLR through  focusing  on T-cell  to investigate  whether  LLR  could  induce  the  potential  function  involving
in  protection  as  a vaccine.  Four  groups  of nude  mice  were  transfused  with  CD4+/CD8+ T-cells  isolated
from  LLR-immunized  (primed)  and LLR-unimmunized  (naïve)  mice  via  intraperitonea  (i.p.)  respectively.
Consequently,  the  adoption  mice  were  challenged  with  mice-origin  wild  rotavirus  EDIM  (Epizootic  Diar-
rhea  of  Infant  Mice)  by  intragastric  administration.  Series  of  fecal/serum  samples  were  collected  and  viral
shedding,  then  serum  IgA/IgG  and  secreted  IgA  were  assayed.  Compared  to  the mice  transfused  with  T
lymphocytes  from  naïve  mice,  the  nude  mice  transfused  with CD4+ T lymphocytes  from  primed  mice
induce  fecal  and serum  IgA  increasing  more  rapidly,  and have  a shorter  duration  of virus shedding  too.
Whereas,  no signiﬁcant  difference  in  virus  clearance  was  found  between  the  mice  transfused  with  CD8+ T
lymphocytes  isolated  from  primed  and  naïve  mice.  Therefore,  we  cleared  the  distinct  roles  of transfused
+ + +CD4 /CD8 T lymphocytes  for  rotavirus  clearance  in  nude  mice,  that  the  viral  clearance  conducted  by CD4
T  lymphocytes.  Meanwhile,  it  has  ability  to  help  induction  of  LLR speciﬁc  immunogenicity.  Comparing
with  the  transfusion  of cell  from  primed  and  naïve  mice,  LLR can induce  CD4+ T lymphocytes  mem-
ory  which  is  a potential  index to  reﬂect the  immunogenicity  and  protection,  while  CD8+ T  lymphocytes
remove rotavirus  by  CTL  with  little  memory  ability.
©  2016  The  Authors.  Published  by  Elsevier  B.V.  This  is  an  open  access  article  under the  CC  BY-NC-ND. Introduction
Rotavirus (RV) infection has been highly regarded since 1973
hen the association between rotavirus infection and acute infant
iarrhea was recognized (Bishop, 2009). So far, rotavirus is also
ne of the main etiological agents of severe dehydrating diar-
hea in infants less than 5 years old worldwide. The World
ealth Organization (WHO) has coordinated the Global Rotavirus
urveillance Network since 2008 (Agócs et al., 2014). Although
here is no speciﬁc treatment, attenuated live rotavirus vaccines
ave been veriﬁed to be effective in preventing rotavirus-caused
iarrhea, especially the severe cases. There are ﬁve vaccines
gainst rotavirus infection in the market till now. Two commercial
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/).license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
vaccines, RotaTeq and RotaRix, have been used to prevent rotavirus
infection in dozens of countries and regions (Kollaritsch et al., 2015;
Desselberger et al., 2009), furthermore, two  new rotavirus vaccines,
Rotavac and Rotavin, was licensed in India (Anon, 2016) and Viet-
nam (Dang et al., 2012) respectively. However, previous studies
indicated that RotaTeq and RotaRix are less effective in develop-
ing countries than in developed ones (Jiang et al., 2010), impeding
their introduction in other countries including China. In fact, the
LLR vaccine (Lanzhou Lamb derived Human Rotavirus Vaccine) has
been authorized to use in China since 2000 and it is the only vac-
cine approved as rotavirus vaccine in China till now (Soares-Weiser
et al., 2012). Besides, there are also several other rotavirus vac-
cines completed or undergoing phase III clinical trials in China.
From 2006 to September 2014, more than 54 million doses of LLR
vaccines have been lot released. However, there are still several
confusions about the using of LLR, since there are limited pub-
lished reports referred to preclinical or clinical effectiveness of LLR
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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accine against infant gastroenteritis (Fu et al., 2007, 2012, 2010;
e et al., 2013).
In this article we focus on the evaluation of effectiveness of LLR
accine in animal models, instead of in human beings, and intend
o look for a way for evaluation of the effectiveness of LLR to under-
tand other novel vaccines well before implantation in children. To
e noted, the immunogenicity is the principal consideration in the
valuation of vaccine’s effectiveness. Although the immunogenicity
tudies of RotaTeq and RotaRix have been already conducted in ani-
als and clinical trials, no related report has been found about the
mmunogenicity of LLR. Concluding from the previous studies IgA
nd IgG are normal indicators as evaluating the immunogenicity of
otavirus vaccines (Blutt et al., 2012; Westerman et al., 2005). More-
ver, the exact correlation of protection remained indeterminate
Franco et al., 2006; Ofﬁt, 1994; Blutt et al., 2008), even the levels of
V-speciﬁc serum IgA and fecal sIgA seem to correlate with protec-
ion better (Angel et al., 2012; Patel et al., 2013). The cell-mediated
mmunity, as well as the humoral and mucosal immunity, and the
arliest initiated innate immune response (Holloway and Coulson,
013) against rotavirus were also proven to be signiﬁcant in animal
nd human beings (Franco and Greenberg, 1995; Jaimes et al., 2002,
005; McNeal et al., 1997). It has already been showed that there is
 RV-speciﬁc cytotoxic T cell response in host, such as the passive
ransfer of immune cytotoxic T lymphocytes (CTLs), which, accord-
ng to previous studies, can both protect against acute rotavirus
nduced diarrhea in suckling mice (Ofﬁt and Dudzik, 1990) and clear
he chronic rotavirus infection from adult SCID (severe combined
mmunodeﬁcient) mice (Blutt et al., 2012), but the exact role of T
ymphocytes in preventing primary infection or re-infection is still
nclear.
Therefore, in order to explore the immunological response of
LR, especially in which kind of T lymphocytes and how the T lym-
hocytes play a role against challenge after primed by LLR vaccine,
e transfused the T lymphocytes isolated from primed mice and
aïve mice into the nude mice. After challenged by mice-origin wild
otavirus EDIM (Epizootic Diarrhea of Infant Mice), we evaluated
he immunological response in the duration of virus infection and
learance. The results showed there are different routes employed
y CD4+ and CD8+ T lymphocytes to evaluate the rotavirus vaccine.
hat would be a new surrogate instead of unsatisﬁed serum anti-
ody for preclinical or clinical trial. This suggests that we should pay
ore attention to passive immunology model and cell-mediated
mmune response induced by rotavirus vaccines in the process of
roduction and evaluation of rotavirus vaccines.
. Materials and methods
.1. Viruses, cells and animals
LLR has been licensed in China since 2000. The titer of LLR vac-
ine used in this study was 6.2 lgCCID50/ml. The rotavirus wild
train EDIM (G16 genotype) was cultured in MA104 cell, using
PMI-1640 medium in 37 ◦C, 5% CO2 incubator. The two-week old
emale mice and nude mice (BALB/c) were provided by and breed
n the Center for Experiment Animal, NIFDC (National Institutes for
ood and Drug Control), and the animal experiment was  approved
y The Animal Care & Welfare Committee of NIFDC, China.
.2. LLR immunization and isolation of CD4+ and CD8+ T
ymphocytesBALB/c mice were divided into two groups (72 mice each
roup) and intragastrically administrated with 0.3 ml  LLR vaccine
group 1) or normal saline (group 2) once a week and three times
otally. Four days after the third immunization, the spleens were217 (2016) 101–106
isolated for separating out T lymphocytes using cell sorter with
Dynabeads FlowComp Mouse CD4+/CD8+ kit (Invitrogen). Brieﬂy,
10 l CD4+ FITC, CD8+ PE, CD3+ PerCP antibodies and 50 l EDTA-
anticoagulated blood from group 1 and group 2 mice were added
into the bottom of BD TruCount Tubes. The mixture was  vortexed
and reacted in dark for 15 min. After adding 450 l red blood cell
lysis buffer and reaction for another 15 min, the proportion and
absolute number of CD4+ and CD8+ T lymphocytes were analyzed
and calculated by using ﬂow cytometry and CellQuest software.
After calculated by using Typan Blue staining, the live CD4+ and
CD8+ T cells were intraperitoneally transfused into nude mice as
soon as possible.
Before transfusion, the IFN--secreting CD4+ and CD8+ T
lymphocytes were analyzed using ELISPOT according to the manu-
facturer’s instruction for evaluating the cell mediated immunity.
Brieﬂy, the immune-spot plate was  coated with puriﬁed IFN-
antibody overnight, followed by blocking with blocking buffer con-
taining 10% fetal bovine serum. Rotavirus vaccine LLR was used
as stimulator with 5.0 lgCCID50 per well in 100 l volume. Subse-
quently, the isolated CD4+ and CD8+ T lymphocytes were added
with 105 per well. After incubated in 37 ◦C, 5% CO2 incubator for
20 h, HRP-labeled anti-IFN- antibody and AEC substrate was used
for detection under CTL ELISPOT reader.
2.3. Passive transfusion of isolated T lymphocytes to nude mice
and challenge with EDIM
The nude mice were divided into four groups (18 nude mice
each group), which were passively transfused with CD4+ T lym-
phocytes isolated from primed (group 3) or naïve (group 4) mice,
and CD8+ T lymphocytes isolated from primed (group 5) or naïve
(group 6) mice, respectively. The amounts of transfused CD4+ and
CD8+ T lymphocytes were 1.5 × 106 and 0.75 × 106 cells/200 l
respectively to obtain the equivalent count of T lymphocytes in
peripheral blood in nude mice as in normal mice. Simultane-
ously, the transfused nude mice were challenged with 0.3 ml  EDIM
(1.2 × 107 CCID50/ml) by gavage. Post-challenged, the status of
these mice were observed and evaluated to determine whether and
how the transfused CD4+ and CD8+ T lymphocytes played a role in
virus clearance, estimated by the indexes including body weight,
rotavirus and RV-IgA in fecal, sera RV-IgA and RV-IgG, intestinal
pathogenecity and viral distribution in small intestine. For this pur-
pose, they were weighed each day from day 0 to day 15 and sampled
the fresh stool from day 0 to day 8 for IgA and viral shedding assay.
The blood samples were collected through venous sinus of eye orbit
from four randomized picked out mice every two  days for IgA and
IgG assay.
2.4. ELISA to measure rotavirus, to measure anti-RV IgA, IgG in
serum and sIgA in feces
Rotavirus in feces was  measured by using ProSpecT Rotavirus
Microplate Assay (OXOID) according to manufacturer’s instruction.
The ELISA to measure rotavirus-speciﬁc IgA, IgG and sIgA has been
used in home. Brieﬂy, plates were coated with diluted EDIM virus
overnight at 4 ◦C, followed by blocked at 37 ◦C for 2 h and dried
overnight at room temperature. Then the serum or treated feces
were incubated in the coated plates with an initial dilution of 1/10.
The amount of antibody was  reﬂected by the values of OD follow-
ing incubation with a HRP-conjugated goat anti-mouse IgA and IgG
antibody. Sample was  considered positive when the ratio of sample
OD/negative OD ≥ 2.1.
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Table  1
The purity assay of the isolated CD4+/CD8+ T cells.
Purity (%, average/stdev)
Group 1 Group 2
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Table 2
The activity assay of the isolated CD4+/CD8+ T cells.
Group 1 Group 2
CD4+
T
cells
Total cells No. (average/stdev) 111.2/7.2 115.2/10.0
Dead cells No. (average/stdev) 5.6/1.7 5.0/1.6
Activity 96.96% 95.66%
+
6 +CD4+ T cells 92.93/4.66 92.63/4.59
CD8+ T cells 92.51/3.26 91.83/2.37
. Results
.1. Isolation and transfusion of CD4+/CD8+ T lymphocytes
In order to mimic  the natural status of CD4+/CD8+ T lympho-
ytes circulating in peripheral blood of normal mice, the accounts
f transfused CD4+/CD8+ T lymphocytes should keep consistence
ith that in normal mice. To achieve this goal, the purity (Table 1)
nd activity (Table 2) of isolated CD4+/CD8+ T lymphocytes were
ssayed. Subsequently, a serial concentration of T lymphocytes
as transfused (CD4+ T lymphocytes: 4.5 × 106, 1.5 × 106 and
.5 × 106 per 200 l; CD8+ T lymphocytes: 2.25 × 106, 0.75 × 106
nd 0.25 × 106 per 200 l). The results showed that, when CD4+
 lymphocytes and CD8+ T lymphocytes were transfused with
.5 × 106 and 0.75 × 106 cells/200 l respectively, the count of T
ymphocytes in peripheral blood of nude mice was equivalent to
hat in normal mice with the same age. The ELISPOT assay showed
hat there is a minor difference in IFN--secreting T lymphocytes
etween LLR immunized mice and unimmunized mice, that is,
78.8 vs 110.8 IFN--secreting CD4+ T lymphocytes, and 154.8 vs
19.2 IFN--secreting CD8+ T lymphocytes per 100,000 cells as
hown in Fig. 1.
.2. Passively transfused CD4+/CD8+ T lymphocytes shortened
iral shedding
In the group transfused with 1.5 × 106 primed CD4+ T lympho-
ytes, the mice were challenged with EDIM strain and the viral
hedding reached to peak in day 1 post challenged, followed by
 decline to negative in day 4. The viral shedding in the group
ransfused with 1.5 × 106 naïve CD4+ T lymphocytes also reached
o peak in day 1, but declined to negative in day 7, which was  3 days
ater than in primed group (Fig. 2A). In the groups transfused with
6 +.75 × 10 primed CD8 T lymphocytes, the viral shedding reached
o peak in day 1 samely as in CD4+ group, followed by a decline to
egative in day 5, which was 1 day later than that in the group of
.5 × 106 primed CD4+ T lymphocytes, but 1 day earlier than that in
Fig. 1. IFN--secreting CD4+ and CD8+ T cells isolatedCD8
T
cells
Live cells No. (average/stdev) 58.6/4.7 59.2/7.2
Dead cells No. (average/stdev) 5.4/1.8 5.4/2.7
Activity 90.78% 90.88%
the group of 0.75 × 106 naïve CD8+ T lymphocytes (Fig. 2B). What-
ever in groups transfused with primed or naïve CD4+ or CD8+ T
lymphocytes, viral shedding reached to peak in day 1 simultane-
ously. However, the viral shedding would be earlier terminated by
transfused with T lymphocytes isolated from primed mice than that
from naïve mice.
3.3. Passively transfused CD4+ T lymphocytes enhanced sIgA
production in feces but not CD8+ T lymphocytes
In the groups transfused with 1.5 × 106 primed CD4+ T lym-
phocytes, sIgA increased rapidly post challenged with EDIM and
reached the peak and maintained in day 3 and day 4, followed by a
decrease began from day 5 till to negative in day 8. Whereas, sIgA
in control group slowly increased from day 3, reached the peak in
day 5–6 and maintained for 1–2 days, followed by a decline in day 7
(Fig. 3A). However, in the group transfused with 0.75 × 106 primed
CD8+ T lymphocytes, sIgA increased slowly from day 5, reached the
peak and remained the level from day 6 to day 8, which showed no
difference with that in the control group (Fig. 3B).
3.4. Passively transfused CD4+ T lymphocytes enhanced serum
IgA and IgG production but not CD8+ T lymphocytes
The results (Fig. 4A) showed that serum IgA began to rise in
day 3, reached the peak in day 7 followed by a decline from day
9 in group transfused with 1.5 × 106 primed CD4+ T lymphocytes.
However, in the control group serum IgA began to rise in day 5,
which was 2 days later compared to the former group, and the test
value showed that there was  a signiﬁcant difference in the peak
value between the two groups. As sIgA, serum IgA in the group
transfused with 0.75 × 10 primed CD8 T lymphocytes showed no
obvious difference with the control group. In the two  groups, after
challenged, serum IgA began to rise in day 7, reached the peak in
day 11 and maintained (Fig. 4B).
 from LLR immunized and unimmunized mice.
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RV-IgG in the group transfused with 1.5 × 106 primed CD4+ T
ells increased in day 3 post-challenged and reached the peak in
ay 7, which was two-fold higher than that in day 0. However, RV-
gG in control group increased in day 7 and reached the peak in
ay 11, which was 4 days delayed compared to that in the former
roup (Fig. 5A). Similar to sIgA and serum IgA, serum IgG in the
roup transfused with 0.75 × 106 primed CD8+ T lymphocytes also
howed no difference with the control group, with a slowly increas-
ng began on day 5, reached to the peak in day 11, followed by a
ecline (Fig. 5B).
. Discussion
As mentioned in Section 1, the humoral immunity against
otavirus, especially antibody was an important part of immuno-
enicity, while partially proven to be signiﬁcant in animal and
uman beings (Franco and Greenberg, 1995; Jaimes et al., 2002,
005; McNeal et al., 1997). However, the roles of T lymphocytes
nd passive immunology model were limitedly noticed in the
reviously published studies referred the evaluation of rotavirus
accines in clinical trials.
In this study, we evaluated the cell-mediated immunity induced
y LLR vaccine using two-week old nude mice as animal model.
ack to 1990, Ofﬁt and Dudzik performed the passive transfusion of
otavirus-speciﬁc cytotoxic T cells into suckling mice to observe its
ole in protecting against gastroenteritis (Ofﬁt and Dudzik, 1990).
owever, suckling mice were not sufﬁcient to present the function
f T lymphocytes, owing to the existence of autologous T lym-
hocytes and potential maternal antibody. When the competent
mmunogenicity was established, the optimal age for challenge by
DIM would be passed, whereas economic nude mice were intro-
uced to avoid this inﬂuence. The nude mice were transfused with T
ymphocytes via i.p. route as Ofﬁt reported (Ofﬁt and Dudzik, 1990)
nstead of intravenous injection through tail veins, for two-week
ld nude mice were so tiny that intravenous injection through tail
eins was impracticable. As expected in this study, both the trans-
Fig. 3. Feces IgA changes in nude mice after transfused with CD4+ (A) and CD8(B) T cells isolated from LLR-immunized and unimmunized nude mice.
fused CD4+ and CD8+ T lymphocytes can be detected in peripheral
blood through intraperitoneal route trasfusion.
Besides the route of transfusion, another issue should be noticed,
that is the precise count of transfused T lymphocytes. Human
RV-speciﬁc CD4+ T lymphocytes circulating in blood can be trans-
migrated to the small intestine that attributed to their expression
of intestinal homing receptor 47 (Rojas et al., 2003; Weitkamp
et al., 2005; Parra et al., 2014a), while adoptively transferred CD8+
T cells leave the circulation and enter the intestinal tract after
binding to speciﬁc receptors (vascular addressins) located on spe-
cialized capillary endothelial cells (Berg et al., 1989). However, the
efﬁcacy of uptake depended on the expression of such receptors
in small intestine of nude mice. Therefore, the precise count of
transfused CD4+/CD8+ T lymphocytes is crucial for evaluating virus
clearance. In order to obtain the equivalent count of T lympho-
cytes in peripheral blood in nude mice as same as in normal mice,
a serial concentration of T lymphocytes was transfused (CD4+ T
lymphocytes: 4.5 × 106, 1.5 × 106 and 0.5 × 106 per 200 l; CD8+
T lymphocytes: 2.25 × 106, 0.75 × 106 and 0.25 × 106 per 200 l).
Finally, the results showed that our goal could be achieved when
CD4+ T lymphocytes and CD8+ T lymphocytes were transfused with
1.5 × 106 and 0.75 × 106 cells/200 l respectively.
Paradox existed in the function of T lymphocytes against
rotavirus infection. Nude mice have been reported to recover from
murine rotavirus-caused gastroenteritis in the absence of a sig-
niﬁcant antibody or a functional T-cell response (Eiden et al.,
1986). Recent studies also showed that circulating RV-T lympho-
cytes seem to have a relatively poor functional proﬁle compared
to tetanus toxoid and inﬂuenza (Parra et al., 2014b). RV-speciﬁc
cytotoxic T cells, contrast to these reports, have been proven to
passively protect against gastroenteritis in suckling mice (Ofﬁt
and Dudzik, 1990). Therefore, to re-explore the role of RV-speciﬁc
T cells, induced by rotavirus vaccine LLR in rotavirus clearance,
two-week old nude mice were passively transfused with CD4+ or
CD8+ T cells separately that isolated from primed mice.
+ (B) T cells isolated from LLR-immunized and unimmunized nude mice.
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Compared to control group, the mice passively transfused
D4+ T lymphocytes from primed mice expedited and enhanced
he production of serum IgA, IgG and sIgA, and shortened the
uration of viral shedding. The results demonstrated that, as
xpected, rotavirus speciﬁc CD4+ T lymphocytes can be induced
n mice through immunization with LLR vaccine, and the passively
ntraperitoneally transfusion of LLR-primed CD4+ T lymphocytes
ransfer the immunological memory to nude mice for virus clear-
nce. Previous studies proved that the memory CD4+ T lymphocytes
nduced an earlier ampliﬁcation and proliferation of B cells than
aïve CD4+ T lymphocytes (MacLeod et al., 2011). The rapid action
f antibodies in our study was also motivated by the memory CD4+
 lymphocytes speciﬁc to LLR vaccine.
Interestingly, unlike CD4+ T lymphocytes, there was  no much
ifference between primed and naïve CD8+ T lymphocytes in virus
learance and antibody production in nude mice. In the previous
tudies, CD4+ T lymphocytes alone were able to protect rotavirus
nfection, whereas it cannot be achieved with only CD8+ T lympho-
ytes (VanCott et al., 2001). Moreover, in the infection models of
oxvirus and listeria monocytogenes, the initiation of the memory
unction of CD8+ T lymphocytes partly depended on CD4+ T lym-
hocytes (Novy et al., 2011). In our study, CD8+ T cell and CD4+ T
ymphocytes were passively transfused to nude mice separately.
onsequently, the immunological memory of CD8+ T lymphocytes
annot be activated without CD4+ T lymphocytes. Therefore, the
oordination of CD4+ and CD8+ T lymphocytes in rotavirus infec-
ions should be studied further.
Our ﬁndings demonstrated that, available nude mice were suc-
essfully used in evaluation of rotavirus vaccine, especially enhance
ell-mediated immunity induced by rotavirus vaccine. In addition,
s a lamb originated human rotavirus vaccine, LLR induced CD4+ cells response had the ability of immunological memory, accel-
rated virus clearance and rapid production of IgA, and shortened
he viral shedding in nude mice compared to control which plays a
redominant role in viral clearance. Disparately, LLR-induced weak
Fig. 5. Serum IgG changes in nude mice after transfused with CD4+ (A) and CD8+ (B) T cells isolated from LLR-immunized and unimmunized nude mice.
CD8+ T lymphocytes response, without the help of CD4+ T lympho-
cytes, cleared virus infection through CTL instead of immunological
memory, which was  the same as in control group.
Another issue is that the percentage of antigen speciﬁc T
lymphocytes may  need to be determined in the transfused T lym-
phocytes, which could be the major contributor to the immunity.
Previous studies showed that higher frequencies of RV speciﬁc
IFN--secreting CD8+ and CD4+ T lymphocytes circulate in symp-
tomatically infected adults and RV-exposed laboratory workers,
compared with healthy volunteers, but low level of IFN--secreting
CD8+ and CD4+ T lymphocytes in children with RV-induced diar-
rhea (Jaimes et al., 2002; Rojas et al., 2003; Mesa et al., 2010).
Several studies also found that circulating RV-speciﬁc T lympho-
cytes have a poor functional proﬁle or rotavirus is a relatively poor
inducer of circulating memory T lymphocytes that secrete IFN-
(Jaimes et al., 2002; Parra et al., 2014b). In this study, T lymphocytes
isolated from spleen of mice was used for passive transfusion, so we
also evaluated the roles of IFN--secreting CD4+ and CD8+ T lym-
phocytes isolated from spleen of mice in cell-mediated immunity
against rotavirus re-infection. The ELISPOT assay showed that there
is a minor difference in IFN--secreting T lymphocytes between LLR
primed and naïve mice. However, the difference of IFN--secreting
CD4+ T lymphocytes between LLR primed and naïve mice (178.8 vs
110.8 per 100,000 cells) was more remarkable than the difference
of IFN--secreting CD8+ T lymphocytes between LLR primed mice
and naïve mice (154.8 vs 119.2 per 100,000 cells). The results ver-
iﬁed the above ﬁndings once again indirectly, that IFN--secreting
CD4+ T lymphocytes played a more important role in cell-mediated
immunity against rotavirus infection than IFN--secreting CD8+ T
lymphocytes.
In summary, the cell-mediated immunity against rotavirus was
proven to be signiﬁcant in mice once more, especially the immuno-
logical memory transferred by RV speciﬁc CD4+ T lymphocytes. It
provides a new way to indicate the effectiveness of rotavirus vac-
cines in animal or human beings.
+ (B) T cells isolated from LLR-immunized and unimmunized nude mice.
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